| Verfasser: |
Pisters, R.
van Vugt, S. P. G.
Brouwer, M. A.
Elvan, A.
ten Holt, W. L.
Zwart, P. A. G.
Kirchhof, P.
Crijns, H. J. G. M.
Hemels, M. E. W. |
| Dokumenttyp: |
Artikel |
| Erscheinungsdatum: |
2017 |
| Reihe/Periodikum: |
Pisters , R , van Vugt , S P G , Brouwer , M A , Elvan , A , ten Holt , W L , Zwart , P A G , Kirchhof , P , Crijns , H J G M & Hemels , M E W 2017 , ' Real-life use of Rivaroxaban in the Netherlands : data from the Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registry ' , Netherlands Heart Journal , vol. 25 , no. 10 , pp. 551-558 . https://doi.org/10.1007/s12471-017-1009-9 |
| Schlagwörter: |
Atrial fibrillation
/ Rivaroxaban
/ XANTUS
/ Non-VKA oral anticoagulation
/ RANDOMIZED CONTROLLED-TRIAL
/ ORAL ANTICOAGULATION
/ WARFARIN
/ AF
/ DABIGATRAN
/ APIXABAN
/ OUTCOMES
/ ASPIRIN |
| Sprache: |
Englisch |
| Permalink: |
https://search.fid-benelux.de/Record/base-29186713 |
| Datenquelle: |
BASE;
Originalkatalog |
| Powered By: |
BASE |
| Link(s) :
|
https://cris.maastrichtuniversity.nl/en/publications/314bf891-3e2b-47b9-a8c7-6f51a199e4a4 |
